Non-Langerhans cell histiocytosis: Difference between revisions
CSV import Tag: Reverted |
No edit summary Tag: Manual revert |
||
| Line 29: | Line 29: | ||
{{stub}} | {{stub}} | ||
{{No image}} | {{No image}} | ||
Revision as of 13:00, 18 March 2025
Non-Langerhans cell histiocytosis is a group of rare diseases characterized by the accumulation of non-Langerhans cells, which are a type of white blood cell, in various organs and tissues. These diseases can affect both children and adults.
Classification
Non-Langerhans cell histiocytosis can be classified into several types, including Rosai-Dorfman disease, Juvenile xanthogranuloma, Erdheim-Chester disease, and Reticulohistiocytosis. Each of these diseases has unique clinical features and may affect different organs and tissues.
Symptoms
The symptoms of non-Langerhans cell histiocytosis vary depending on the specific type of disease and the organs and tissues affected. Common symptoms may include skin lesions, bone pain, and organ dysfunction.
Diagnosis
The diagnosis of non-Langerhans cell histiocytosis is typically made based on a combination of clinical findings, imaging studies, and histopathological examination of tissue samples. Immunohistochemical staining is often used to confirm the diagnosis.
Treatment
The treatment of non-Langerhans cell histiocytosis depends on the specific type of disease and the severity of symptoms. Treatment options may include surgery, radiation therapy, chemotherapy, and targeted therapies.
Prognosis
The prognosis of non-Langerhans cell histiocytosis varies widely depending on the specific type of disease and the organs and tissues affected. Some forms of the disease are self-limiting and resolve without treatment, while others may be chronic or life-threatening.
See also
References
<references />